|
Logo placeholder
|
| Location |
Tokyo, Japan |
| Type |
Research Institute |
| Website |
https://www.tmig.or.jp/ |
| Focus Areas |
[Alzheimer's Disease](/diseases/alzheimers), [Vascular Dementia](/diseases/vascular-dementia), [Aging](/mechanisms/aging) |
| Departments |
Department of Aging Science |
The Tokyo Metropolitan Institute of Gerontology (TMIG) is Japan's premier research institute dedicated to comprehensive research on aging and age-related diseases. Established in 1972 in Itabashi-ku, Tokyo, TMIG has served as a national center for gerontology research, contributing significantly to understanding the biological, psychological, and social aspects of aging.
The institute's research programs span basic science to clinical investigation, with particular strength in Alzheimer's disease, vascular dementia, and the neuroscience of aging. TMIG maintains collaborations with universities, hospitals, and research institutions throughout Japan and internationally, advancing the field of gerontology and geriatrics.
The Department of Aging Science investigates fundamental mechanisms of aging:
- Cellular Senescence: Studies on cellular aging, senescence-associated secretory phenotype (SASP), and senolytic interventions.
- Neuroinflammation: Investigation of chronic neuroinflammation and its role in age-related cognitive decline.
- Metabolic Changes: Studies on how metabolic alterations contribute to brain aging and neurodegeneration.
TMIG maintains a comprehensive Alzheimer's disease research program:
- Epidemiology: Large-scale studies on dementia prevalence, incidence, and risk factors in Japanese populations.
- Biomarker Studies: Development and validation of diagnostic and prognostic biomarkers.
- Intervention Research: Testing lifestyle, pharmacological, and nutritional interventions for cognitive decline prevention.
Given Japan's high stroke prevalence, TMIG has strong research on vascular cognitive impairment:
- Binswanger's Disease: Clinical and pathological studies on subcortical vascular dementia.
- Post-stroke Dementia: Investigation of cognitive outcomes following cerebrovascular events.
- Vascular Risk Factors: Studies on hypertension, diabetes, and their contributions to vascular cognitive impairment.
TMIG is internationally recognized for research on healthy longevity:
- Blue Zone Studies: Investigation of areas in Japan with exceptional longevity.
- Cognitive Reserve: Studies on factors that protect against cognitive decline in aging.
- Functional Independence: Research on maintaining independence in activities of daily living.
- Aging Research Building: Specialized facilities for neuroscience and aging research.
- Clinical Research Center: Human subjects research facilities including memory clinic.
- Animal Research Facility: Preclinical research on aging and neurodegeneration models.
| Focus Area |
Programs |
Status |
| Dementia epidemiology |
Community-based cohort studies |
Ongoing |
| Biomarker validation |
Japanese cohort studies |
Active |
| Intervention trials |
Lifestyle modification |
Various phases |
| Care research |
Dementia care models |
Active |
| Researcher |
H-index |
Focus Areas |
| Kenichi M. Meguro |
75 |
Alzheimer's disease, epidemiology |
| Satoshi K. Hirayama |
60 |
Neurobiology of aging |
| Yasuhiko K. Saito |
55 |
Vascular dementia |
| Takashi S. Wada |
50 |
Cognitive aging |
- Japanese dementia epidemiology: Major longitudinal studies on dementia incidence and risk factors.
- Cognitive function norms: Establishment of normative data for cognitive testing in Japanese populations.
- Care model development: Development and evaluation of community-based dementia care approaches.
- Healthy longevity research: Investigation of factors contributing to exceptional longevity in Japan.
TMIG maintains active international collaborations:
- WHO Collaborating Center: Designation as WHO Collaborating Centre for Dementia Research.
- Asian Network: Leadership in Asian research networks on neurodegeneration.
- Exchange Programs: Researcher exchanges with leading international institutions.
¶ Technology and Infrastructure
TMIG maintains state-of-the-art research infrastructure:
- Animal Facilities: Specialized facilities for aging mouse models and senescence research.
- Imaging Center: MRI and PET facilities for small animal imaging.
- Biobank: Repository of human samples from Japanese cohort studies.
¶ Education and Training
TMIG provides training in gerontology research:
- Graduate Programs: Collaboration with Japanese universities for PhD training.
- Postdoctoral Research: Opportunities for early-career researchers.
- International Training: Hosting international researchers through fellowship programs.
TMIG contributes to policy and public health:
- Government Advisory: Providing expertise to Japanese Ministry of Health policies.
- Public Education: Brain health education campaigns for Japanese population.
- Care Standards: Development of evidence-based dementia care guidelines.
TMIG's strategic directions include:
- Super-Aging Society: Research on challenges of rapidly aging population.
- Functional Preservation: Maintaining independence and quality of life in aging.
- Prevention Strategies: Lifestyle and medical approaches to prevent cognitive decline.
- Long-term Care: Improving dementia care systems and caregiver support.